Literature DB >> 30455615

Why should radiation oncology do translational research? [corrected].

Rut Cañas1, Isabel Linares1,2, Ferran Guedea1,2, Miguel Ángel Berenguer1,2.   

Abstract

Radiological Oncology, like the rest of medical specialties, is beginning to provide can personalized therapies. The ongoing scientific advances enable a great degree of precision in diagnoses and therapies. To fight cancer, from a radiotherapy unit, requires up-to-date equipment, professionals with different specialties working in synchrony (doctors, physicists, biologists, etc.) and a lot of research. Some of the new therapeutic tendencies are immunotherapy, nanoparticles, gene therapy, biomarkers, artificial intelligence, etc. A new clinical paradigm in which new professional networks are inevitable is arising. The mission of translational research is to become a scientific engine in the clinical space.

Entities:  

Keywords:  Artificial intelligence; Gene therapy; Nanoparticles; Networks; Radiotherapy; Translational research

Year:  2018        PMID: 30455615      PMCID: PMC6234255          DOI: 10.1016/j.rpor.2018.10.008

Source DB:  PubMed          Journal:  Rep Pract Oncol Radiother        ISSN: 1507-1367


  47 in total

1.  Transforming insurance coverage into quality health care: voltage drops from potential to delivered quality.

Authors:  J M Eisenberg; E J Power
Journal:  JAMA       Date:  2000-10-25       Impact factor: 56.272

2.  The role of nanomaterials in translational medicine.

Authors:  Erin Lavik; Horst von Recum
Journal:  ACS Nano       Date:  2011-05-24       Impact factor: 15.881

3.  Durvalumab after chemo-radiotherapy in stage III non-small cell lung cancer.

Authors:  Jaseela Chiramel; Rebecca Tay; Raffaele Califano
Journal:  J Thorac Dis       Date:  2018-04       Impact factor: 2.895

4.  Treatment delivery verification in brachytherapy: Prospects of technology innovation.

Authors:  Kari Tanderup; Christian Kirisits; Antonio L Damato
Journal:  Brachytherapy       Date:  2018 Jan - Feb       Impact factor: 2.362

Review 5.  Emergence of stereotactic body radiation therapy and its impact on current and future clinical practice.

Authors:  Robert D Timmerman; Joseph Herman; L Chinsoo Cho
Journal:  J Clin Oncol       Date:  2014-08-11       Impact factor: 44.544

6.  What difference would it make if cancer were eradicated? An examination of the Taeuber paradox.

Authors:  N Keyfitz
Journal:  Demography       Date:  1977-11

7.  Translational science and the hidden research system in universities and academic hospitals: a case study.

Authors:  Bryn Lander; Janet Atkinson-Grosjean
Journal:  Soc Sci Med       Date:  2010-11-27       Impact factor: 4.634

8.  Combined high dose rate brachytherapy and external beam radiotherapy for clinically localised prostate cancer.

Authors:  Iosif Strouthos; Georgios Chatzikonstantinou; Nikolaos Zamboglou; Natasa Milickovic; Sokratis Papaioannou; Dimitra Bon; Constantinos Zamboglou; Claus Rödel; Dimos Baltas; Nikolaos Tselis
Journal:  Radiother Oncol       Date:  2018-05-12       Impact factor: 6.280

Review 9.  Pulsed dose rate brachytherapy - is it the right way?

Authors:  Janusz Skowronek
Journal:  J Contemp Brachytherapy       Date:  2010-10-13

10.  Identification and validation of single-sample breast cancer radiosensitivity gene expression predictors.

Authors:  Martin Sjöström; Johan Staaf; Patrik Edén; Fredrik Wärnberg; Jonas Bergh; Per Malmström; Mårten Fernö; Emma Niméus; Irma Fredriksson
Journal:  Breast Cancer Res       Date:  2018-07-04       Impact factor: 6.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.